肺炎是内巴塞勒斯-卡尔梅特-盖林 (BCG) 免疫治疗的次要原因
Komeil Alattar1, Sagar Dodhia1, Michael Levi1
1Dartford and Gravesham NHS Trust, Kent, United Kingdom.
Radiology case reports
|June 16, 2025
概括
膀癌的肠道Bacillus Calmette-Guérin (BCG) 治疗很少会导致肺炎. 本案例报告详细介绍了使用仅抗结核药物治疗BCG诱导肺炎的成功治疗方法.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 肠道 Calmette-Guérin (BCG) 是表面膀癌的标准治疗方法.
- 来自BCG治疗的全身并发症很少见,但可能是严重的.
- BCG诱导的肺炎是一种不常见的不良事件,需要迅速识别.
研究的目的:
- 报告在BCG静脉灌注后出现急性呼吸障碍病例.
- 为突出诊断和成功管理BCG诱导的肺炎.
- 强调识别系统性BCG并发症的重要性.
主要方法:
- 一个老年男性患者的病例报告,在BCG治疗后出现急性呼吸不良.
- 诊断工作包括临床评估,病理学,X射线,CT扫描和PET扫描.
- 治疗包括4个月的抗结核药物治疗.
主要成果:
- 这名患者被诊断为BCG诱导的肺炎.
- 仅使用抗结核药物治疗就取得了成功.
- 在治疗期间或治疗后没有报告任何重大不良事件.
结论:
- BCG诱导的肺炎是静脉BCG治疗的罕见但显著的并发症.
- 抗结核药物可以是BCG诱导的肺炎的有效治疗方法.
- 临床医生应在接受这种治疗的患者中保持对全身BCG并发症的高度怀疑指数.
更多相关视频
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
10.7K
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
7.4K
相关概念视频
Pulmonary Tuberculosis II
389
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
389
Pneumothorax-II
389
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
389
Pulmonary Tuberculosis I
335
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
335
Urinary Tract Infection II: Pathophysiology
54
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
54
Pneumonia I: Introduction
345
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
345
Pulmonary Tuberculosis V
249
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
249
